TCIM
BIVV

TIAA CREF Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

TIAA CREF Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-318,109
Closed -$17.2M – 3098
2017
Q4 		$17.2M Buy
318,109
+14,945
+5% +$818K 0.01% 863
2017
Q3 		$17.3M Sell
303,164
-74,061
-20% -$4.34M 0.01% 829
2017
Q2 		$22.7M Sell
377,225
-116,975
-24% -$6.66M 0.02% 698
2017
Q1 		$26.9M Buy
+494,200
New +$24.3M 0.02% 637

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

TIAA CREF Investment Management's BIVV Position: Q1 2018 in Review

TIAA CREF Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 318,109 shares — an estimated $17.2M sold.

TIAA CREF Investment Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $26.9M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • TIAA CREF Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • TIAA CREF Investment Management sold 318,109 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $17.2M.
  • TIAA CREF Investment Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • TIAA CREF Investment Management's Bioverativ Inc. Common Stock position peaked at $26.9M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on TIAA CREF Investment Management's 13F filing for Q1 2018, filed 14 May 2018.